Your browser doesn't support javascript.
loading
Preventing pellagra during isoniazid preventive treatment.
Kapata, Nathan; Zumla, Alimuddin.
Affiliation
  • Kapata N; Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia; PANDORA-ID-NET, University of Zambia-University College London Medical School (UNZA-UCLMS) University of Research and Training Project, University Teaching Hospital, Lusaka RW1X, Zambia. Electronic address: nkapata@gmail.com.
  • Zumla A; PANDORA-ID-NET, University of Zambia-University College London Medical School (UNZA-UCLMS) University of Research and Training Project, University Teaching Hospital, Lusaka RW1X, Zambia; Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, UK; NIHR Biomedical Research Centre, London, UK; UCL Hospitals National Health Service Foundation Trust, London, UK.
Lancet Glob Health ; 10(5): e600-e601, 2022 05.
Article in En | MEDLINE | ID: mdl-35427509
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pellagra / Isoniazid Limits: Humans Language: En Journal: Lancet Glob Health Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pellagra / Isoniazid Limits: Humans Language: En Journal: Lancet Glob Health Year: 2022 Document type: Article Country of publication: